Targacept Reports First Quarter 2014 Financial Results

[Business Wire] – Targacept, Inc. , a clinical-stage biopharmaceutical company developing novel NNR Therapeuticsâ„¢, today reported its financial results for the first quarter ended Marc more

View todays social media effects on TRGT

View the latest stocks trending across Twitter. Click to view dashboard

See who Targacept is hiring next, click here to view